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ABSTRACT | The Glittre ADL-test (TGlittre), validated to 
assess the functional capacity of patients with chronic ob-
structive pulmonary disease, has as outcome the shortest 
total time required to complete it. To date, little is known 
about the time that healthy individuals take to perform it. 
This study aimed to describe the total and shortest times 
spent to perform TGlittre in a sample of healthy adults, and 
to assess the reliability of the test in this population. The 
subjects underwent spirometry pre- and post-bronchodi-
lator, anthropometric assessment, International Physical 
Activity Questionnaire and two TGlittre. 35 subjects were 
evaluated (15 men), of 29±6 years of age, with forced vital 
capacity (FVC) of 96±10.6% and forced expiratory volume 
in the first second (FEV1) of 97.6±9.26%, in % of predicted, 
and FEV1/FVC of 0.86±0.05; height of 1.72±0.11m; weight 
of 24.5±3.62kg and body mass index of 24.2±3.87kg/m2, 
being 74.3% and 25.7% with low and moderate physical 
activity level, respectively. The mean time spent on the 
test with better performance was 2.62±0.34min. There 
was no difference in performance among age groups 
(p>0.05). There was a mean reduction of 6.3±5.8% in the 
time between TGlittre1 and TGlittre2, however, this differ-
ence was not statistically significant (p>0.05). An intra-
class correlation coefficient of 0.88 (p<0.05) between the 
time of TGlittre1 and 2 was found. The results suggest that 
in a sample of healthy adults, the shortest and mean time 
to complete the test are 2.03 and 2.62min, respectively, 
and that TGlittre is reliable in these subjects.
Keywords | Exercise Tolerance; Activities of Daily Living.
Resumo | O teste de AVD-Glittre (TGlittre), validado para 
avaliar a capacidade funcional de indivíduos com doença 
pulmonar obstrutiva crônica, possui como desfecho o me-
nor tempo despendido para completá-lo. Até o presente 
momento, pouco se sabe acerca desse tempo no desem-
penho de indivíduos saudáveis. O objetivo do estudo foi 
avaliar o tempo total de realização do TGlittre em uma 
amostra de indivíduos adultos saudáveis, o tempo míni-
mo de execução do teste, assim como a reprodutibilidade 
do teste nessa população. Os sujeitos foram submetidos 
à espirometria pré e pós-broncodilatador, avaliação an-
tropométrica, Questionário Internacional de Atividade 
Física e dois TGlittre. Foram avaliados 35 indivíduos (15 
homens) de 29±6 anos, com capacidade vital forçada 
(CVF) de 96±10,6%, volume expiratório forçado no pri-
meiro segundo (VEF1) de 97,6±9,26%, em % do previsto, 
e VEF1/CVF de 0,86±0,05; altura de 1,72±0,11m; peso de 
72,3±12,8kg e índice de massa corpórea de 24,5±3,62kg/
m2, sendo que 74,3% e 25,7% tinham níveis baixo e mo-
derado de atividade física, respectivamente. A média de 
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tempo despendido no teste com melhor desempenho foi de 
2,62±0,34min. Não se encontrou diferença na execução entre as 
faixas etárias (p>0,05). Houve redução, em média, de 6,3±5,8% 
no tempo entre o TGlittre1 e TGlittre2, porém essa diferença não 
foi estatisticamente significante (p>0,05). Encontrou-se um coe-
ficiente de correlação intraclasse de 0,88 (p<0,05) entre os tem-
pos do TGlittre1 e TGlittre2. Os resultados demonstraram que, 
em uma amostra de adultos jovens saudáveis, o tempo mínimo 
e a média para completar o teste são de 2,62min e 2,03min, res-
pectivamente, e que este é reprodutível nesses indivíduos.
Descritores | Tolerância ao Exercício; Atividades Cotidianas.
RESUMEN | La prueba AVD-Glittre (PGlittre), validada para eva-
luar la capacidad funcional de sujetos con enfermedad pulmonar 
obstructiva crónica, tiene como resultado el menor tiempo de-
dicado para completarla. Hasta el presente, poco se conoce so-
bre este tiempo en el rendimiento de sujetos sanos. Para eso, el 
objectivo fue evaluar el tiempo total de realización de la PGlittre 
en una muestra de sujetos adultos sanos, el tiempo mínimo de 
ejecución de la prueba, así como su reproductibilidad en la po-
blación. Los sujetos se sometieron a la espirometría pre y pos 
broncodilatador, a la evaluación antropométrica, al Cuestionario 
Internacional de Actividad Física y a dos PGlittre. Se han evalua-
dos 35 sujetos (15 varones) de 29±6 años, con capacidad vital 
forzada (CVF) de 96±10,6%, volumen espiratorio forzado en el 
primer segundo (VEF1) de 97,6±9,26%, en % del previsto, y VEF1/
CVF de 0,86±0,05; altura de 1,72±0,11m; peso de 72,3±12,8kg e 
índice de masa corporal de 24,5±3,62kg/m2, en el que el 74,3% y 
25,7% tenían bajo y moderado nivel de actividad física, respec-
tivos. La media de tiempo en la prueba con mejor rendimien-
to fue de 2,62±0,34min. No se ha encontrado diferencias en la 
ejecución entre el rango de edad (p>0,05). Ha ocurrido una re-
ducción, en media, de 6,3±5,8% en el tiempo entre la PGlittre1 y 
PGlittre2, pero esa diferencia no ha sido significante estadistica-
mente (p>0,05). Se ha encontrado un coeficiente de correlación 
interclase de 0,88 (p<0,05) entre los tiempos de la PGlittre1 y 
PGlittre2. Los resultados mostraron que, en una muestra de adul-
tos jóvenes sanos, el tiempo mínimo y la media para completar 
la prueba fueron de 2,62min y 2,03min, respectivamente, y que 
esto es reproductible en estos sujetos.
Palabras clave | Tolerancia a la Actividad Física; Actividades 
Cotidianas.
INTRODUCTION
Functional capacity is defined as the ability of an 
individual to perform activities of daily living (ADL)1 
including self-care (eating, bathing, dressing), work, 
household chores and leisure2. Factors such as aging, 
obesity3 and the presence of chronic degenerative dis-
eases4, especially cardiopulmonary ones5, may be re-
sponsible for impaired functional capacity.
Considered an important treatment outcome in 
patients with cardiopulmonary diseases, functional ca-
pacity can be assessed by a variety of instruments such 
as questionnaires and field tests5. Among them, the 
six-minute walk test is the most commonly used because 
it is simple to apply, low cost6 and validated in several 
populations7-10. However, it only involves the walking 
activity in the plan. The Glittre-ADL Test (TGlittre), 
which was developed and validated for patients with 
chronic obstructive pulmonary disease (COPD), seems 
to be more representative of ADL as it involves a set of 
common tasks in daily life apart from walking, as sit-
ting-standing, climbing up and down stairs and moving 
objects in different heights11.
Since TGlittre is a relatively new instrument and 
has been little investigated, there is a lack of informa-
tion about it. The knowledge about the performance 
of healthy subjects in this test, for example, is limited. 
Skumlien, et al.11, in the validation study, conducted an 
evaluation in healthy volunteers and showed that the 
fastest time to complete it without violating the pro-
tocol was of 2 minutes. However, the authors did not 
mention the number of participants, the mean time 
they took to complete the test or the sample charac-
teristics. In another study, Corrêa, et al.12 evaluated the 
performance of 10 healthy subjects in TGlittre, with a 
mean age of 64 years, and found that they took a mean 
time of 3.3 minutes (95% CI: 2.8 to 3.8min) to com-
plete it. However, it is known that the functional ca-
pacity tends to decrease with aging due to a gradual 
reduction in muscle strength and maximal oxygen up-
take3. Thus, by investigating the performance of healthy 
young subjects in TGlittre, the influence of factors such 
as age, normal body mass index, absence of cardiopul-
monary disorders and low to moderate physical activity 
levels could provide better information about the min-
imum and expected time for healthy young individuals, 
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who are expected to have no impairment of functional 
capacity.
Therefore, this study aimed to evaluate the perfor-
mance of healthy young adults in TGlittre and the min-
imum time to perform the test, as well as to verify the 
reliability of TGlittre in this sample.
METHODOLOGY
Subjects
The study sample consisted of healthy individuals 
from both sexes, recruited from the community and 
selected in a non-probabilistic intentional way. The 
inclusion criteria were: between 20 and 39 years of 
age, and clinical stability (characterized by the ab-
sence of any acute illness within 6 weeks prior to 
the study). Subjects with forced vital capacity (FVC) 
<80% (post-bronchodilator), forced expiratory volume 
in the first second (FEV1) <80% predicted (post-bron-
chodilator) and FEV1/FVC<0.75 (post-broncho-
dilator), with a history of musculoskeletal, cardio-
vascular, respiratory or any other chronic disorders, 
high physical activity level rated by the short form 
of the International Physical Activity Questionnaire 
(IPAQ)13 and unable to perform any of the study 
 evaluations were excluded. 
The study was approved by the Ethics Committee 
on Human Research of Santa Catarina State University 
(UDESC), Florianópolis, (SC), Brazil (protocol num-
ber 225/2011). All participants signed an informed 
consent form.
Procedures
Initially, the subjects were interviewed and anthropo-
metric data were collected. Then, subjects performed a pul-
monary function test pre- and post- bronchodilator (BD). 
Subsequently, the IPAQ short form13 and two TGlittre, 
with an interval of 30min between them, were applied.
Anthropometric measurements
The anthropometric data were collected with 
the subject barefoot and in the upright position. The 
weight and height were measured by a Tanita digital 
scale (BC-558) and Sanny stadiometer, respectively. 
The body mass index (BMI) was calculated using the 
formula below.
BMI = weight (kg)
 height (m)2
Pulmonary function test
The pulmonary function was evaluated with an 
EasyOneTM spirometer (NDD, Switzerland), in ac-
cordance with the procedures of the American Thoracic 
Society/European Respiratory Society14. Forced expira-
tory volume in the first second in absolute value (FEV1) 
and percentage of predicted (FEV1% pred), forced vi-
tal capacity in absolute value (FVC) and percentage of 
predicted (FVC% pred), and FEV1/FVC were assessed. 
The predicted values were based on the equation by 
Pereira, et al.15.
Physical activity level
The level of physical activity was assessed using the 
IPAQ short form, which was validated for the Brazilian 
population in 200113. This questionnaire consists of 8 
questions and allows the discrimination of activity du-
ration. Three intensity levels are determined: low, mod-
erate and high.
Glittre ADL-test (TGlittre)
TGlittre consists of a standardized circuit of 10 me-
ters which must be performed in the shortest possible 
time with the following sequence: from the sitting po-
sition, the individual stands and walks; halfway, he or 
she goes up and down two steps (17cm height × 27cm 
width) and then walks again. At the end, there are two 
shelves with three objects weighing 1kg each, posi-
tioned on the top shelf (at shoulder height) to be moved 
down, one by one, to the lower shelf (at waist height) 
and subsequently to the ground; next, the objects must 
be placed again on the lower shelf, and finally moved to 
the top shelf; afterwards, the individual walks back, sits 
again and immediately starts another lap following the 
same ADL-circuit until 5 laps are completed. During 
the test the subject must carry a backpack weighing 
2.5kg for women and 5.0kg for men11.
The blood pressure was checked at the beginning and 
at the end of the test. The pulse oxygen saturation (SpO2), 
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heart rate (HR) and dyspnea perception, assessed by the 
Modified Borg Scale16, were evaluated at every lap and 
at the beginning and immediately after the end of the 
test. If the subject presented systolic and diastolic blood 
pressures above 180mmHg and 100mmHg, respectively, 
and a SpO2≤85%, the test would be interrupted. The to-
tal time to complete the test was registered.
Statistical Analysis
Data were analyzed using the Statistical Package 
for Social Sciences (SPSS, version 20.0). The descrip-
tive statistics was used for all variables (mean, standard 
deviation, median and 95% confidence interval). Data 
normality was verified by the Shapiro-Wilk test. To 
verify the correlation between performance on TGlittre 
and anthropometric variables, the Pearson correlation 
coefficient was used. The intraclass correlation coeffi-
cient (ICC) was used to assess the reliability of the test. 
The Wilcoxon test was used to verify the difference be-
tween the variation of the HR and the maximum HR 
in percentage of age-predicted (maxHR%pred), in both 
tests. The statistical significance level was 5% (p<0.05).
RESULTS
Forty-three individuals participated in the study. 
Of these, eight were excluded: five for not being able 
to perform the pulmonary function test; one for hav-
ing FEV1<80% predicted; one for showing activity level 
classified as “high” on IPAQ; and one for being a former 
smoker, with a family history of COPD, in addition to 
presenting the FEV1/FVC ratio of 0.7, i.e., very close to 
the lower limit of normality. Thus, 35 completed the pro-
tocol: 15 (42.8%) males; 26 (74.3%) with low-intensity 
physical activity; and 9 (25.7%) with moderate intensity 
physical activity.
Sample characterization is presented in Table 1. 
Out of the 35 subjects, 30 (85.7%) showed better per-
formance in the second TGlittre. The mean time spent 
on the second test was 2.62±0.34min (95% CI: 2.48-
2.72min). The shortest time to perform the test was 
2.03min. The performance in TGlittre did not corre-
late with age (r=-0.17, p=0.322), body mass (r=0.08, 
p=0.637) or height (r=-0.22, p=0.197).
There was no statistically significant reduction in 
the mean time spent between the first and second 
TGlittre (p>0.05). An ICC of 0.88 (p<0.05) was found 
between the time spent in TGlittre1 and TGlittre2, as 
shown in Figure 1. The data relating to the perfor-
mance in both ADL-Glittre tests, the variation of HR 
and dyspnea perception during the tests and their ICC 
are described in Table 2. There was no difference be-
tween the variation of HR (p=0.62) and the maxHR% 
predicted (p=0.07), in both tests. Besides, the subjects 
performed the first and second TGlittre with a mean 
of 66.9% and 68.6% of maxHR%pred, respectively.
The sample was divided into four age groups (20-24, 
25-29, 30-34 and 35-39 years old), and there was no 
statistically significant difference in the performance in 
TGlittre among them (p>0.05) (Table 3). A significant 
difference in body mass was observed – it was statis-
tically higher in the group of people who were 30-34 
years old in comparison to the groups of individuals 
who were 20-24 and 25-29 years old (p<0.05). 
Table 1. Sample characterization
Mean SD Median
CI95%
LL UL
Age (years) 29.0 6.00 28.0 26.9 31.1
Body mass (kg) 72.3 12.8 69.5 67.9 76.7
Height (m) 1.72 0.11 1.70 1.68 1.75
BMI (kg/m2) 24.5 3.62 23.6 23.2 25.7
Initial HR (bpm) 76.7 13.4 76 72.1 81.3
FVC (L) 4.39 1.11 4.21 4.01 4.77
FVC (%prev) 96.0 10.6 97.0 92.4 99.7
FEV1 (L) 3.71 0.86 3.57 3.41 4.00
FEV1 (%prev) 97.6 9.26 97.0 94.4 100.0
FEV1 /FVC 0.86 0.05 0.86 0.83 0.87
SD: standard deviation; CI95%: confidence interval 95%; LL: lower limit; UL: upper limit; BMI (kg/m2): body mass index in kilograms per square meter; FEV1 (L): forced expiratory volume in one second in 
liters; FEV1 (%prev): forced expiratory volume in one second in percentage of predicted; FVC (L): forced vital capacity in liters; FVC (%prev): forced vital capacity in percentage of predicted
Reis, et al. Glittre ADL-test in healthy adults
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Table 2. Performance in ADL-Glittre Tests 1 and 2
TGlittre 1 
Mean±SD 
TGlittre 2
Mean±SD
Intraclass  
Correlation  
(CI95%)
Time spent (min) 2.80±0.36 2.62±0.34 0.88* (0.20-0.96)
∆HR (bpm) 48.8±14.5 49.8±15.8 0.69* (0.38-0.84)
∆dyspnea  
perception
0.5 [0.5-2]** 1 [0.5-2]** 0.92* (0.86-0.94)
SD: standard deviation; CI95%: confidence interval 95%; TGlittre: ADL-Glittre Test; ∆HR: variation 
between initial and final HR; ∆dyspnea perception: variation between initial and final dyspnea; 
*p<0.05 in intraclass correlation: excelent correlation (0.8-1.0), good correlation (0.6-0.8),  
satisfactory correlation (0.4-0.6) and weak correlation (0.2-0.4); ** median [interquartile range: 
25-75%]
TGlittre 1 (min)
TG
lit
tr
e 
2 
(m
in
)
3.5
3.0
2.5
2.0
1.5
1.5 2.0 2.5 3.0 3.5 4.0
4.0
Figure 1. Intraclass correlation coefficient among the time spent in the 
ADL-Glittre Tests (TGlittre) 1 and 2 (ICC=0.88; p<0.05)
Table 3. Total time to perform TGlittre, anthropometric and pulmonary 
function variables in each age group
Age groups (years)
20-24
(n=9;  
22.2% M)
25-29
(n=9;  
55.6% M)
30-34
(n=9; 
55.6% M)
35-39
(n=8;  
37.5% M)
TGlittre 
(min)
2.62±0.43 2.67±0.30 2.58±0.33 2.53±0.33
Body mass 
(kg)
66.2±3.87 68.7±2.46 83.3±3.45* 70.8±4.07
Height (m) 1.66±0.85 1.73±0.12 1.78±0.11 1.70±0.10
BMI (kg/m2) 24.2±3.87 22.6±2.46 26.4±3.45 24.5±4.07
FVC 
(%prev)
87.9±6.75 95.4±7.20 97.7±12.5 104.0±9.60
FEV1 
(%prev)
90.7±7.23 98.1±6.74 97.3±11.0 105.0±6.46
FEV1/FVC 0.89±0.47 0.87±0.40 0.82±0.39 0.84±0.52
SD: standard deviation; M: male; BMI (kg/m2): body mass index in kilograms per square meter; 
FEV1 (%prev): expiratory volume in one second in percentage of predicted; FVC (%prev): forced 
vital capacity in percentage of predicted. *p<0.05 vs. age groups 20-24 and 25-29 years old
DISCUSSION
This study aimed to evaluate the total time re-
quired for healthy young adults to perform TGlittre. 
Furthermore, it also aimed to verify the reliability of 
this test in this population.
Skumlien, et al.11, in a pilot study, found that the 
shortest time healthy subjects took to perform TGlittre 
was 2min. However, the subjects’ characteristics (age 
or anthropometric measures) were not mentioned. The 
present study found a minimum time that is very close 
to theirs, confirming that healthy young adults need 
at least 2min to perform the test without violating the 
protocol, i.e., without running, skipping any steps or 
moving more than one object at a time. Thus, these re-
sults may indicate that young individuals that perform 
the test at a time close to this possibly do not have any 
impairment of functional capacity.
Comparing the performance of these subjects to 
patients with cardiopulmonary diseases in TGlittre, it 
is clear that healthy people need less time to complete 
it. In a study by Valadares, et al.17, patients with heart 
failure spent a mean time of 6.30min (95% CI: 2.80-
9.80min) to perform the test. Skumlien, et al.11 and 
Corrêa, et al.12 found the mean times of 4.67min (25-
75% interquartile range: 3.40-5.47min) and 5.30min 
(95% CI: 3.20-11.3min), respectively, for patients with 
COPD. These results were considerably higher than 
those found in the present study. However, the mean 
age of the subjects in this study is lower than the pa-
tients studied by these authors, and it is known that, be-
sides the presence of cardiopulmonary disease, another 
factor associated with decreased functional capacity is 
the aging process3. Therefore, this difference may have 
been influenced by the two combined factors. Corrêa, et 
al.12 compared the performance of patients with COPD 
with that of healthy subjects, paired by sex, age and BMI, 
and found that TGlittre is able to detect functional lim-
itations induced by COPD. Observing the performance 
of these subjects, it is clear that they spent a mean time 
of 3.30min (95% CI: 2.80-3.80min)12, which is longer 
than that observed in the present study. Thus, TGlittre 
seems to be able to differentiate the functional capac-
ity of young individuals from elderly ones. However, 
studies with a more specific design for this purpose are 
needed to confirm these findings.
Iwama, et al.3, in the study that developed reference 
equations for the six-minute walk test (6MWT) in a 
healthy Brazilian population, found that age is directly 
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related to the walked distance. In the present study, no 
significant differences were observed in the performance 
of TGlittre among age groups and no correlation was 
found between the time spent on the test and the age 
of the individuals. One possible explanation is that the 
study evaluated only subjects aged less than 40 years old 
and that the age range was too small to cause changes in 
functional capacity induced by the aging process.
Another factor that seems to be related to functional 
capacity reduction is the increased body mass18. Studies 
have shown that body mass correlates with the distance 
on the 6MWT3,18,19. Obese people, for example, com-
monly show reduced lean body mass and an increase 
in work load during exercise, thus showing worse per-
formance in the 6MWT18. However, this study found 
no association between body mass and the time spent 
on TGlittre. But observing the BMI of these subjects, 
it was noticed that only 3 of them were obese, which 
could have caused the statistical difference among the 
groups, since they were over 30 years old. Moreover, the 
obesity was in a lower degree, which may not have been 
sufficient to cause a significant decline in functional 
capacity. 
It is known that TGlittre is reliable in patients 
with COPD. Skumlien, et al.11, in their validation 
study, used two TGlittre on two consecutive days in a 
group of 52 patients, stages 2 and 3 of GOLD20, and 
a strong correlation was found between them (r=0.93, 
p<0.05). In this study, two tests were applied to healthy 
young adults, and there was an excellent ICC between 
them. Moreover, variations in HR and dyspnea per-
ception presented good to excellent ICCCCI21 be-
tween the two tests. There was no statistical difference 
in HR  variation and the individuals reached approx-
imately 67% maxHR%pred in both tests. These results 
 demonstrate that the test is also reliable in this sample, 
despite its short time, that the individuals perform both 
tests at the same effort level and the submaximal nature 
of the task.
Additionally, no significant differences were found 
between TGlittre 1 and 2. However, there was a mean 
reduction of 6.3% in the execution time of the second 
test compared to the first one. This value was very close 
to that found by Skumlien, et al.11, which was 7%. The 
improved performance on the second test is probably 
due to a learning effect. This effect is also described in 
other tests that evaluate the functional capacity, such as 
the 6MWT19. However, it is expected that this effect 
does not persist for more than a few weeks, as in the 
6MWT11,19.
This was the first study to investigate the per-
formance of healthy adults in TGlittre. Nevertheless, 
reference equations for it remain unknown. Since it 
is a relatively new test, more studies are needed to 
determine reference values for different age groups 
of healthy population, allowing a better interpreta-
tion of clinical findings in populations of patients 
with diseases that can lead to impaired functional 
capacity. 
CONCLUSION
In summary, healthy young adults take, in average, 
2.62min to complete TGlittre, and the test seemed to 
be reliable in a sample of healthy young adults, allowing 
a better comparison of the functional capacity between 
healthy subjects and functional impaired patients. 
Moreover, the study demonstrated a need for at least 
2min to complete the TGlittre tasks.
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